A Highly Predictive Risk Model for Pacemaker Implantation After TAVR

JACC: Cardiovascular Imaging

Volumn 10, Issue 10, 2017, Pages 1139-1147

  Maeno, Yoshio ^a   Abramowitz, Yigal ^a   Kawamori, Hiroyuki ^a   Kazuno, Yoshio ^a   Kubo, Shunsuke ^a   Takahashi, Nobuyuki ^a   Mangat, Geeteshwar ^a   Okuyama, Kazuaki ^a   Kashif, Mohammad ^a   Chakravarty, Tarun ^a   Nakamura, Mamoo ^a   Cheng, Wen ^a   Friedman, John ^a   Berman, Daniel ^a   Makkar, Raj R ^a   Jilaihawi, Hasan ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

calcification; pacemaker; predictors; transcatheter aortic valve implantation; transcatheter aortic valve replacement

Indexed keywords

CALCIUM; IOPAMIDOL;

AGED; AORTIC VALVE STENOSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; BALLOON DILATATION; BRADYCARDIA; CALCIFICATION; CALIFORNIA; COMPLETE HEART BLOCK; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; DISEASE SEVERITY; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART SEPTUM; HUMAN; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIDETECTOR COMPUTED TOMOGRAPHY; PACEMAKER IMPLANTATION; PERCUTANEOUS AORTIC VALVE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SENSITIVITY AND SPECIFICITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VERY ELDERLY; AORTIC VALVE; CALCINOSIS; DECISION SUPPORT SYSTEM; DIAGNOSTIC IMAGING; FACTUAL DATABASE; HEART BUNDLE BRANCH BLOCK; HEART PACING; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; TRANSLUMINAL VALVULOPLASTY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BALLOON VALVULOPLASTY; BUNDLE-BRANCH BLOCK; CALCINOSIS; CARDIAC PACING, ARTIFICIAL; DATABASES, FACTUAL; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LOGISTIC MODELS; LOS ANGELES; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85017412274     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2016.11.020     Document Type: Article

References (22)

1. Makkar, R.R., Fontana, G.P., Jilaihawi, H., et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366 (2012), 1696–1704.
2. Nazif, T.M., Dizon, J.M., Hahn, R.T., et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. J Am Coll Cardiol Intv 8 (2015), 60–69.
3. Abdel-Wahab, M., Mehilli, J., Frerker, C., et al. Comparison of balloon-expandable vs self- expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311 (2014), 1503–1514.
4. Khatri, P.J., Webb, J.G., Rodés-Cabau, J., et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 158 (2013), 35–46.
5. Jilaihawi, H., Chakravarty, T., Weiss, R.E., Fontana, G.P., Forrester, J., Makkar, R.R., Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-CoreValve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv 80 (2012), 128–138.
6. Webb, J., Gerosa, G., Lefèvre, T., et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol 64 (2014), 2235–2243.
7. Erkapic, D., De Rosa, S., Kelava, A., Lehmann, R., Fichtlscherer, S., Hohnloser, S.H., Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 23 (2012), 391–397.
8. De Torres-Alba, F., Kaleschke, G., Diller, G.P., et al. Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. J Am Coll Cardiol Intv 9 (2016), 805–813.
9. Tarantini, G., Mojoli, M., Purita, P., et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention 11 (2015), 343–350.
10. Binder, R.K., Webb, J.G., Toggweiler, S., et al. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. J Am Coll Cardiol Intv 6 (2013), 462–468.
11. Hamdan, A., Guetta, V., Klempfner, R., et al. Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol Intv 8 (2015), 1218–1228.
12. Jilaihawi, H., Makkar, R.R., Kashif, M., et al. A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 15 (2014), 1324–1332.
13. Khalique, O.K., Hahn, R.T., Gada, H., et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. J Am Coll Cardiol Intv 7 (2014), 885–894.
14. Fujita, B., Kütting, M., Seiffert, M., et al. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 17 (2016), 1385–1393.
15. Latsios, G., Gerckens, U., Buellesfeld, L., et al. “Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 76 (2010), 431–439.
16. Jilaihawi, H., Kashif, M., Fontana, G., et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 59 (2012), 1275–1286.
17. Watanabe, Y., Morice, M.-C., Bouvier, E., et al. Automated 3-dimensional aortic annular assessment by multidetector computed tomography in transcatheter aortic valve implantation. J Am Coll Cardiol Intv 6 (2013), 955–964.
18. DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988), 837–845.
19. Herrmann, H.C., Thourani, V.H., Kodali, S.K., et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation 134 (2016), 130–140.
20. Nijhoff, F., Abawi, M., Agostoni, P., Ramjankhan, F.Z., Doevendans, P.A., Stella, P.R., Transcatheter aortic valve implantation with the new balloon-expandable SAPIEN 3 versus SAPIEN XT valve system: a propensity score-matched single-center comparison. Circ Cardiovasc Interv, 8, 2015, e002408.
21. Jilaihawi, H., Chin, D., Vasa-Nicotera, M., et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 157 (2009), 860–866.
22. Piazza, N., de Jaegere, P., Schultz, C., Becker, A.E., Serruys, P.W., Anderson, R.H., Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 1 (2008), 74–81.